Wednesday's close is the market's freshest read: the S&P 500 rose 0.22% and the Nasdaq gained 0.16%, ending a three-day losing streak, after the Treasury said it would increase buybacks of long-dated debt, pulling the 30-year yield down to 5.19% from Tuesday's 5.28% close. Gold jumped 3.8% and silver 4.5% as the lower-yield backdrop revived the safe-haven bid, while SMH fell another 1.55% — a second straight session of chip weakness that extends Tuesday's 4.09% semiconductor-sector selloff to a two-day drop of roughly 5.6%. The chip trade split hard beneath that headline number: storage names Western Digital and Seagate kept bleeding (down 6.9% and 7.9% Wednesday alone) as rising yields pressured the sector's most extended trade, while Marvell surged 9.9% on a new $12.2 billion custom-silicon deal with Google that also knocked Nvidia and Broadcom onto the back foot. Moderna surged 177% after a Merck-partnered melanoma vaccine hit its Phase 3 goal. U.S. government debt passed $40 trillion for the first time, and Target's earnings beat added to a mixed retail picture ahead of Walmart's report Thursday morning.
The broad market rebounded Wednesday after the Treasury's buyback announcement calmed bond yields — the S&P 500 rose 0.22% and the Nasdaq gained 0.16%, ending a three-day slide. SMH didn't participate: it fell another 1.55% on top of Tuesday's 4.09% drop, a two-day, sector-wide move MarketWatch frames as a speed bump rather than a trend break, citing past dip-buying opportunities after similar pullbacks. But the sector's second day wasn't uniform — memory and storage names extended their slide while Marvell rallied hard on a fresh AI deal, showing dispersion underneath the index-level number.
Underneath SMH's headline drop, Wednesday split the sector three ways. Western Digital fell 6.87% and Seagate 7.87% — a second straight brutal session for storage, now down roughly 14% and 16% since Monday, as rising yields pressure what's been the most extended trade in chips. SanDisk fell a milder 3.50% after Tuesday's 9.01% drop. Marvell was the outlier, surging 9.85% after Google took a warrant tied to a new custom-silicon deal worth up to $12.2 billion — a deal GuruFocus reports also left Nvidia essentially flat near $219 while Broadcom absorbed fresh selling as investors weighed a new hyperscaler competitor to its custom-chip franchise. Meta, which fell nearly 4% Tuesday on AI-capex-driven free-cash-flow worries and a child-safety trial, recovered about 0.4% Wednesday. Nvidia doesn't report until Aug 26; Wednesday's split tape — SPY up, SMH down, and chipmakers moving in three different directions underneath it — leaves the chip trade's next real signal six trading days out, with the buyback-driven yield relief doing more for the broad market than for AI-linked names specifically.
The Treasury said Wednesday it would increase buybacks of longer-dated debt, and the 30-year yield fell to 5.19% from Tuesday's 5.28% close — a reversal WSJ ties directly to Bessent's long-running focus on capping borrowing costs. Gold jumped 3.84% and silver 4.47% as the lower-yield backdrop revived the safe-haven trade CNBC says now sits under fresh pressure from Trump's Fed criticism.
The yen strengthened to ¥158.28 Thursday morning, down 0.82% from Wednesday's close, moving further from ¥160 as U.S. yields retreated. Trump renewed his criticism of Fed policy Wednesday, calling the current rate system "unfair" while still praising Warsh personally — a split signal ahead of this week's FOMC minutes.
Wednesday's Treasury buyback news buys the market some room, but this week's FOMC minutes are still outstanding, Walmart reports Thursday morning, and Nvidia's Aug 26 report remains the next major single-stock catalyst for the AI trade.
Wednesday's dominant single-stock story dwarfed everything else: Moderna gained 176.97% on positive Phase 3 melanoma-vaccine data shared with Merck. On the losing side, La-Z-Boy fell 16.95% on a Q1 earnings miss and weak guidance, while Bally's continued sliding on a going-concern warning disclosed Friday. Today's tofu-agent batch (six sector-level files: big-banks, cybersecurity, enterprise-software, ev-energy, streaming-media, travel-leisure) contained no tickers at all — every name below was sourced independently from FMP price and news data.
The five chip and chip-adjacent names below are Wednesday's continuation of Tuesday's broad semiconductor selloff (SMH −4.09%, individual names down 7-9%), not a new, unrelated batch of movers — read them alongside the Equities section above for the fuller two-day picture.
Wednesday's reversal came from Bessent's Treasury, not Warsh's Fed: a buyback announcement did what markets had been waiting on FOMC minutes to deliver. Gold's snap-back and SMH's continued weakness show the rally wasn't a uniform risk-on move.
Moderna's 177% surge was the day's biggest single move but sits outside this chain entirely — a company-specific biotech catalyst, not a macro one, and a reminder not every big move belongs to the same story.
Equities: SPY (+0.21%) and QQQ (−0.20%) diverged slightly Wednesday as the S&P ended a three-day slide. SMH (−1.55%) kept falling despite the broader rally, extending Tuesday's 4.09% drop to a two-day 5.58% slide — the market's clearest current divergence, and one splitting into three sub-stories: memory/storage names (WDC, STX) still bleeding on yield pressure, Marvell up nearly 10% on a new Google chip deal, and Meta stabilizing after Tuesday's capex-driven drop.
Commodities & rates: the 30-year Treasury yield fell to 5.19% from Tuesday's 5.28% close after Treasury increased long-bond buybacks. Gold (+3.84%) and silver (+4.47%) both jumped on the lower-yield backdrop, while oil (+0.19%) held roughly flat near its recent high.
FX: the yen strengthened to ¥158.28 Thursday morning as U.S. yields retreated. This week's FOMC minutes are still due, though Wednesday's buyback news already answered part of the question markets had been waiting on them for.
The wildcard: whether Wednesday's relief was a genuine turn or a one-day patch on a structural debt story that crossed $40 trillion the same day. Moderna's 177% biotech surge is a reminder that not every big move this week traces back to rates.